Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

NeuroPace (NPCE) EBIT Margin (2020 - 2025)

NeuroPace (NPCE) has 6 years of EBIT Margin data on record, last reported at 6.65% in Q4 2025.

  • For Q4 2025, EBIT Margin rose 1037.0% year-over-year to 6.65%; the TTM value through Dec 2025 reached 16.34%, up 1078.0%, while the annual FY2025 figure was 16.34%, 1078.0% up from the prior year.
  • EBIT Margin reached 6.65% in Q4 2025 per NPCE's latest filing, up from 9.51% in the prior quarter.
  • Across five years, EBIT Margin topped out at 6.65% in Q4 2025 and bottomed at 107.59% in Q2 2022.
  • Average EBIT Margin over 5 years is 46.19%, with a median of 36.34% recorded in 2023.
  • Peak YoY movement for EBIT Margin: plummeted -7113bps in 2022, then surged 6002bps in 2023.
  • A 5-year view of EBIT Margin shows it stood at 81.98% in 2021, then increased by 6bps to 77.09% in 2022, then soared by 64bps to 28.04% in 2023, then soared by 39bps to 17.02% in 2024, then surged by 61bps to 6.65% in 2025.
  • Per Business Quant database, its latest 3 readings for EBIT Margin were 6.65% in Q4 2025, 9.51% in Q3 2025, and 29.01% in Q2 2025.